I talked last week about the move in oil, and the lag in natural gas.
But natural gas was knocking on the door of a technical breakout. As you can see, that breakout looks to be underway now.
Nat gas is now at $3.25. If history is any indication, it could be in the low $4s soon.
That’s helped by chatter today from OPEC members out vocally supporting the production cut that was agreed to two weeks ago. And the Secretary General of OPEC piled on today by saying the sharp contraction in investments (due to low prices) poses a threat to global oil supply. As we’ve discussed, for those that had the “oil price to zero” arguments earlier in the year, supply changes, so does demand.
With all of this, oil continues to climb higher, testing the June highs today. Here’s another look at the chart.
A break above the June highs of $51.67 would project a move to near $65 (technically speaking, it’s a C-wave). Another big technical level above is $68.60, which is the 61.8% retracement of the move down from almost $95 in late 2014, to the lows of earlier this year. That’s the breakdown in oil prices driven by OPEC’s 2014 refusal to cut production. And now were on the verge of getting the first cut in eight years. So oil is looking like higher levels are coming — it was up another 3% today.
What’s does it mean for stocks? As we’ve discussed, for much of the year, lower oil has meant lower stocks, and higher oil has meant higher stocks.
This emerging bullish technical and fundamental backdrop for energy should be very good for stocks. Remember, higher energy prices, in this environment, removes the risk of another oil price shock-to-sentiment (good for stocks, good for the economy). And it means producers can start producing again, downstream businesses can fill capacity, and we can start seeing some of the hundreds of thousands of U.S. jobs replenished that have been lost over the past two years.
Since OPEC rigged lower oil prices back in late 2014, we’ve had over 100 North American energy company bankruptcies. Some of those have/are reorganizing and emerging with lean balance sheets into what could be a hot recovery in energy prices. I’ll talk about some tomorrow.
The Billionaire’s Portfolio is up 23% year-to-date — that’s nearly four times the return of the S&P 500 during the same period. We recently exited a big FDA approval stock for a quadruple, and we’ve just added a new pick to the portfolio — following Warren Buffett into one of his favorite stocks. If you haven’t joined yet, please do. Click here to get started and get your portfolio in line with our Billionaire’s Portfolio.
As you might recall, since I’ve written this daily note starting in January, I’ve focused on a few core themes.
First, central banks are in control. They’ve committed trillions of dollars to manufacture a recovery. They’ve fired arguably every bullet possible (“whatever it takes”). And for everyone’s sake, they can’t afford to see the recovery derail – nor will they. With that, they need stocks higher. They need the housing recovery to continue. They need to maintain the consumer and growing business confidence that they have manufactured through their policies.
A huge contributor to their effort is higher stocks. And higher stocks only come, in this environment, when people aren’t fearing another big shock/ big shoe to drop. The central banks have promised they won’t let it happen. To this point, they’ve made good on their promise through a number of unilateral and coordinated defensive maneuvers along the way (i.e. intervening to quell shock risks).
The second theme: As the central banks have been carefully manufacturing this recovery, the Fed has emerged with the bet that moving away from “emergency policies” could help promote and sustain the recovery. It’s been a tough road on that front. But it has introduced a clear and significant divergence between the Fed’s policy actions and that of Japan, Europe and much of the rest of the world. That creates a major influence on global capital flows. The dollar already benefits as a relative safe parking place for global capital, especially in an uncertain world. Add to that, the expectation of a growing gap between U.S. yields and the rest of the world, and more and more money flows into the dollar… into U.S. assets.
With that in mind, this all fuels a higher dollar and higher U.S. asset prices. And when a dollar-denominated asset begins to move, it’s more likely to attract global speculative capital (because of the dollar benefits).
With that in mind, let’s ignore all of the day to day news, which is mostly dominated by what could be the next big threat, and take an objective look at these charts.
U.S. Stocks
Clearly the trend in stocks since 2009 is higher (like a 45 degree angle). Since that 2009 bottom in stocks, we’ve had about 4 higher closes for every 1 lower close on a quarterly basis. That’s a very strong trend and we’ve just broken out to new highs last quarter (above the white line).
U.S. Dollar
This dollar chart shows the distinct effect of divergent global monetary policy and flows to the dollar. You can see the events annotated in the chart, and the parabolic move in the dollar. Any positive surprises in U.S. economic data as we head into the year end will only drive expectations of a wider policy gap — good for a higher dollar.
Oil
We looked at this breakout in oil last week after the OPEC news. Oil traded just shy of $50 today. That’s 17% higher since September 20th.
Oil trades primarily in dollars. And we have a catalyst for higher oil now that OPEC has said it will make the first production cut in eight years. That makes oil a prime spot for speculative capital (more “fuel” for oil). And as we’ve discussed in recent days, weeks and months… higher oil, given the oil price bust that culminated earlier this year, is good for stocks, and good for the economy.
What’s the anti-dollar trade? Gold. As we discussed yesterday, gold has broken down.
If we keep it simple and think about this major policy divergence, we have plenty of reasons to believe a higher dollar and higher stocks will continue to lead the way.
The Billionaire’s Portfolio is up 23% year-to-date — that’s nearly four times the return of the S&P 500 during the same period. We recently exited a big FDA approval stock for a quadruple, and we’ve just added a new pick to the portfolio — following Warren Buffett into one of his favorite stocks. If you haven’t joined yet, please do. Click here to get started and get your portfolio in line with our Billionaire’s Portfolio
Stocks continue to chop around as we head into the big jobs report this week. But the dollar has been a mover today, so has gold.
Let’s take a look at the chart of gold. It has broken down technically.
You can see the longer term downtrend in gold since it topped out in 2011. And we’ve had a corrective bounce this year, which was contained by this descending trendline. And today we broke the trend that describes this bullish technical correction (i.e. the trend continues lower).
A lot of people own gold. And it’s a very emotional trade. Whenever I talk about negative scenarios for gold, the hate mail is sure to follow.
We’ve talked quite a bit about the drivers of the gold trade. I want to revisit that today.
Gold has been a core trade for a lot of people throughout the crisis period. When Lehman failed in 2008, it shook the world, global credit froze, banks were on the verge of collapse, the global economy was on the brink of implosion—people ran into gold. Gold was a fear–of–the–unknown–outcome trade.
Then the global central banks responded with massive backstops, guarantees, and unprecedented QE programs. The world stabilized, but people ran faster into gold. Gold became a hyperinflation–fear trade.
Gold went on a tear from sub–$700 bucks to over $1,900 following the onset of global QE (led by the Fed).
Gold ran up as high as 182%. That was pricing in 41% annualized inflation at one point (as a dollar for dollar hedge). Of course, inflation didn’t comply.
Still eight years after the Fed’s first round of QE (and massive global responses), we have just 13% cumulative inflation over the period.
So the gold bugs overshot in a big way. We’ve looked at this next chart a few times over the past several months. This tells the story on why inflation hasn’t met the expectations of the “run-away inflation” theorists.
This chart above is the velocity of money. This is the rate at which money circulates through the economy. And you can see to the far right of the chart, it hasn’t been fast. In fact, it’s at historic lows. Banks used cheap/free money from the Fed to recapitalize, not to lend. Borrowers had no appetite to borrow, because they were scarred by unemployment and overindebtedness. Bottom line: we get inflation when people are confident about their financial future, jobs, earning potential…and competing for things, buying today, thinking prices might be higher, or the widget might be gone tomorrow. It’s been the opposite for the past eight years.
When this reality of low-to-no inflation and global economic malaise became clear, even after rounds of Fed QE, there were a LOT of irresponsible people continuing to tout gold as an important place in everyone’s portfolio, even at stratospheric levels. People bought gold at $1900 and have since lost as much as 40% on the value of their investment – an investment that was supposed to “hedge” against inflation.
On that note, today the IMF downgraded U.S. growth estimates for the year from 2.2% to just 1.6% — in a year that many were initially expecting to be a good year, nearing trend growth levels (3%-3.5%). So eight years from the inception of the Fed’s extraordinary policies, the case for gold remains weak and an investment with more risk than reward.
The Billionaire’s Portfolio is up 23% year-to-date — that’s nearly four times the return of the S&P 500 during the same period. We recently exited a big FDA approval stock for a quadruple, and we’ve just added a new pick to the portfolio — following Warren Buffett into one of his favorite stocks. If you haven’t joined yet, please do. Click here to get started and get your portfolio in line with our Billionaire’s Portfolio.
Oil popped over $3 from the lows of the day (as much as 7%) on news OPEC has agreed to a production cut.
We’ve talked a lot throughout the year about the price of oil. When it collapsed to the $20s, it put the entire energy industry on bankruptcy watch.
Of course, oil bounced sharply from those lows of February as central banks stepped in with a coordinated response to stabilize confidence. Not so coincidentally, oil bottomed the same day the Bank of Japan intervened in the currency markets.
The oil price bust all started back in November of 2014, the evening of Thanksgiving Day, when OPEC pulled the rug out from under the oil market by vowing not to make production cuts, in an attempt to crush the nascent shale industry. At that time, oil was trading around $73.
You can see in this chart, it never saw that price again.
OPEC was successful in heavily damaging the U.S. shale industry through low oil prices, but it has damaged OPEC countries, too.
What will the news of an agreement on a production cut mean?
A policy shift from OPEC can be very powerful. In 1986, the mere hint of an OPEC policy move sent oil up 50% in just 24 hours. And as we discussed earlier in the year, the relationship between the price of oil and stocks this year has been tight. At times, stocks have traded almost tick for tick with oil.
Take a look at this chart.
An oil price back in the $60s would be a catalyst for a big run in stocks into the year end. For a stock market that has been rudderless surrounding a confused Fed and an important election, this oil news could kick it into gear.
If you’re looking for great ideas that have been vetted and bought by the world’s most influential and richest investors, join us atBillionaire’s Portfolio. We have just exited an FDA approval stock for a quadruple. And we’ll be adding a two new high potential billionaire owned stocks to the portfolio very soon. Don’t miss it. Join us here.
The debate last night was entertaining. It’s sad to see how the media manipulates facts and cherry picks quotes to fit their narrative.
But that’s what they do and it ultimately shapes views for voters, unfortunately.
Today, I want to focus on China and Trump’s comments on China’s currency manipulation. Everyone knows the U.S. has lost jobs to China. Everyone knows China has become the world’s manufacturer. But not everyone knows how they did it.
Is it just because the labor is so cheap? Or is there more to it?
There’s more to it. A lot more.
China’s biggest and most effective tool is and always has been its currency. China ascended to the second largest economy in the world over the past two decades by massively devaluing its currency, and then pegging it at ultra–cheap levels.
Take a look at this chart …
In this chart, the rising line represents a weaker Chinese yuan and a stronger U.S. dollar. You can see from the early 80s to the mid 90s, the value of the yuan declined dramatically, an 82% decline against the dollar. They trashed their currency for economic advantage – and it worked, big time. And it worked because the rest of the world stood by and let it happen.
For the next decade, the Chinese pegged their currency against the dollar at 8.29 yuan per dollar (a dollar buys 8.29 yuan).
With the massive devaluation of the 80s into the early 90s, and then the peg through 2005, the Chinese economy exploded in size. It enabled China to corner the world’s export market, and suck jobs and foreign currency out of the developed world. This is precisely what Donald Trump is alluding to when he says “China is stealing from us.”
Their economy went from $350 billion to $3.5 trillion through 2005, making it the third largest economy in the world.
This next chart is U.S. GDP during the same period. You can see the incredible ground gained by the Chinese on the U.S. through this period of mass currency manipulation.
And because they’ve undercut the world on price, they’ve become the world’s Wal-Mart (sellers to everyone) and have accumulated a mountain for foreign currency as a result. China is the holder of the largest foreign currency reserves in the world, at over $3 trillion dollars (mostly U.S. dollars). What do they do with those dollars? They buy U.S. Treasuries, keeping rates low, so that U.S. consumers can borrow cheap and buy more of their goods – adding to their mountain of currency reserves, adding to their wealth and depleting the U.S. of wealth (and the cycle continues).
The U.S. woke up in 2005, and started threatening tariffs against Chinese goods unless they abandoned their cheap currency policies. China finally conceded (sort of). They agreed to abandon the peg to the dollar, and to start appreciating their currency.
They allowed the currency to strengthen by about 4.5% a year from 2005 through 2013. That might sound good, but that was a drop in the bucket compared to the double digit pace the Chinese economy was growing at through most of that period. Still, the U.S. passively threatened along the way, but allowed it to continue.
With that, the Chinese economy has ascended to the second largest economy in the world now – on pace to the biggest soon (though it still has just an eight of the per capita GDP as the U.S.). But China’s currency is a bigger threat, at this stage, than just the emergence of China as an economic power. The G-20 (the group of the world’s top 20 economies) has had China’s weak currency policy at the top of its list of concerns for a reason.
The current global imbalances are the underlying cause of the global financial crisis, and China’s currency is at the heart of it.
And without a more fairly valued yuan, repairing those imbalances — those lopsided economies too dependent upon either exports or imports — isn’t going to happen. It’s a recipe for more cycles of booms and busts … and with greater frequency.
Are big tariffs the answer? Historically that’s a recipe for disaster, economically and geopolitically.
What’s the solution? I’ve thought that the Bank of Japan will ultimately crush the value of the yen, as the answer to Japan’s multi-decade economic malaise and as an answer to the stagnant global economic recovery. It’s an answer for everyone, except China. A much weaker yen could crush the China threat, by displacing China as the world’s exporter.
If you’re looking for great ideas that have been vetted and bought by the world’s most influential and richest investors, join us atBillionaire’s Portfolio. We have just exited an FDA approval stock for a quadruple. And we’ll be adding a two new high potential billionaire owned stocks to the portfolio very soon. Don’t miss it. Join us here.
All eyes are on the Presidential debate/face-off tonight. Heading into the event, stocks are lower, yields are lower and the dollar is lower — all a “risk-off” tone.
And the VIX (implied S&P 500 vol/an indicator of uncertainty) has popped higher from the very low levels it had returned to as of Friday. Speculators are out today making bets on a political firework show tonight, and thus betting on more uncertainty in the outcome and in post-election policy making.
If we step back a bit though, given the difficulties in getting through the legislative process, the biggest potential market influence from the election may be more about the prospects of getting a fiscal stimulus package done, rather than the many promises that are made on an campaign trail. Both candidates have been out promising a spending package to boost the economy. And on the heals of a package from Japan, and the unknown risks from Brexit, the idea is becoming more politically palatable.
As we discussed on Friday, the Fed has taken a strategically more pessimistic public view on the economy, in effort to underpin the current economic drivers in place (stability, low rates and incentives to reach for risk).
Following the Fed and BOJ events last week, the 10-year yield is back in the 1.50s and sitting in a big technical level. This will be an important chart to keep an eye on tomorrow.
If you’re looking for great ideas that have been vetted and bought by the world’s most influential and richest investors, join us atBillionaire’s Portfolio. We have just exited an FDA approval stock for a quadruple. And we’ll be adding a two new high potential billionaire owned stocks to the portfolio very soon. Don’t miss it. Join us here.
Yesterday we talked about the two big central bank events in focus today. Given that the Bank of Japan had an unusual opportunity to decide on policy before the Fed (first at bat this week), I thought the BOJ could steal the show.
Indeed, the BOJ acted. The Fed stood pat. But thus far, the market response has been fairly muted – not exactly a show stealing response. But as we’ve discussed, two key hammers for the BOJ in achieving a turnaround in inflation and the Japanese economy are: 1) a weaker yen, and 2) higher Japanese stocks.
Their latest tweaks should help swing those hammers.
Bernanke wrote a blog post today with his analysis on the moves in Japan. Given he’s met with/advised the BOJ over the past few months, everyone should be perking up to hear his reaction.
Let’s talk about the moves from the BOJ …
One might think that the easy, winning headline for the BOJ (to influence stocks and the yen) would be an increase in the size of its QE program. They kicked off in 2013 announcing purchases of 60 for 70 trillion yen ($800 billion) a year. They upped the ante to 80 trillion yen in October of 2014. On that October announcement, Japanese stocks took off and the yen plunged – two highly desirable outcomes for the BOJ.
But all central bank credibility is in jeopardy at this stage in the global economic recovery. Going back to the well of bigger asset purchases could be dangerous if the market votes heavily against it by buying yen and selling Japanese stocks. After all, following three years of big asset purchases, the BOJ has failed to reach its inflation and economic objectives.
They didn’t take that road (the explicit bigger QE headline). Instead, the BOJ had two big tweaks to its program. First, they announced that they want to control the 10-year government bond yield. They want to peg it at zero.
What does this accomplish? Bernanke says this is effectively QE. Instead of telling us the size of purchase, they’re telling us the price on which they will either or buy or sell to maintain. If the market decides to dump JGB’s, the BOJ could end up buying more (maybe a lot more) than their current 80 trillion yen a year. Bernanke also calls the move to peg rates, a stealth monetary financing of government spending (which can be a stealth debt monetization).
Secondly, the BOJ said today that they want to overshoot their 2% inflation target, which Bernanke argues allows them to execute on their plans until inflation is sustainable.
It all looks like a massive devaluation of the yen scenario plays well with these policy moves in Japan, both as a response to these policies, and a complement to these policies (self-reinforcing). Though the initial response in the currency markets has been a stronger yen.
If you’re looking for great ideas that have been vetted and bought by the world’s most influential and richest investors, join us atBillionaire’s Portfolio. We have just exited an FDA approval stock for a quadruple. And we’ll be adding a two new high potential billionaire owned stocks to the portfolio very soon. Don’t miss it. Join us here.
The biggest mover in the market today was Sarepta Therapeutics, up as much as 100% on an FDA approval. We owned the stock in our Billionaire’s Portfolio, where we made more than 330% on the position in 18 months.
Today, I want to talk a bit about the back story on it; why Sarepta was one of the best risk/reward trades in the market.
Since 2012, the stock has gone from $3 to $45, back to $21, up to $55, back down to $12, up to $40, back down below $12, back to $25 and now back to $12.
Still, two years ago, Sarepta was a little–known stock. Perceptive Advisors, a specialist biotech hedge fund, stepped in and bought 9.5% of the stock on the prospects that the company would get approval on its drug, Eteplirsen, to treat Duchenne Muscular Dystrophy. And they’ve endured all of the swings along the way.
Perceptive was the best performing hedge fund in 2015. It put up a 52% return, after fees, in a year when almost every hedge fund and mutual fund lost money, and the S&P barely eked out a gain. Among the winners, a private investment in Acerta, which was said to give Perceptive “the biggest return in the history of pharmaceuticals investing.” The fund also had a huge 2013 with four stocks that did over 500%.
Since 1999, the fund has returned north of 40% annualized, before fees. Clearly, they have a record of success picking the winners in the complex (but high rewards) biotech space. With that, we followed them into Sarepta.
In the past year, Sarepta became a highly covered and written about stock—with a lot of drama, because the big catalyst was due to come this year.
The FDA held an advisory committee meeting earlier in the year, where the committee reviewed the drug and gave their recommendation to the FDA on whether or not Eteplirsen should receive “accelerated approval.”
For context, Sarepta’s primary competitor’s drug was rejected by the FDA late last year. This meant Sarepta had the only drug on the table that can potentially treat Duchenne MD.
This review meeting was a highly controversial and publicized event that included personal testimonies from boys and families suffering from DMD.
Despite this, the committee concluded the meeting by recommending against the approval of Eteplirsen, by a very thin margin. Still, we knew there was a good chance that it could be overruled by the FDA’s top drug advisor, Janet Woodcock.
Perceptive’s Joe Edelman publicly said the same. We had one of, if not, the best biotech investors in the world saying “I find it hard to believe that the FDA would turn it down.”
What some investors missed? The important consideration was that Sarepta was seeking “accelerated approval.” For terminal diseases that have no treatment, the bar for approval in that “accelerated” application to the FDA is significantly lowered. They look at safety. They look at efficacy (does it work?). By rule, the FDA must give a lot of flexibility on the latter.
It was always widely agreed that Sarepta’s drug is safe. What was highly debated was efficacy. The FDA committee’s contention was that the trial studies were too lean to prove effectiveness, even though the testimonials said otherwise (patients and doctors alike had been begging the FDA to approve the drug for over a year). Given that it was safe, but highly debated on efficacy, the risk/reward of approving favored an approval, given the FDA was working on the lower approval bar detailed above.
Though the analyst community was mixed on the perceived outcome, it was believed that, on an approval, the stock would trade near $60.
We had two scenarios:
Scenario 1: If the FDA approves Eteplirsen in an accelerated approval, the stock could be worth $60 a share. It’s not uncommon for biotech stocks to jump 200% in one day when its drug is approved by the FDA. That would be a 260% return from its share price of just months ago.
Scenario 2: If Sarepta’s drug was not approved, the stock would probably sell back below $5 a share, based on Sarepta’s cash and intellectual property.
But the beauty of the trade: Even if Eteplirsen did not get accelerated approval, the company would get another chance to go back to the FDA with more studies and data, and Eteplirsen could have gotten approval next year—so our downside would be time.
Additionally, other biotech companies would be interested in Sarepta’s DMD assets even in the case of a non–approval by the FDA, and therefore Sarepta could be acquired at a nice premium.
So we were looking at risking maybe 50% downside or so, to make 5X on the upside—a 8 to 1 risk to reward trade in Sarepta.
As we know now, the news was good! Both for investors and, most importantly, for the boys suffering from the devastating DMD disease. Sarepta stock traded as high as $56.
Invitation to Join Billionaires Portfolio
If you want to participate in stocks that become the big stories on Wall Street … the big event-driven stocks, that pay handsome premiums, join us!
You can click here to subscribe — At BillionairesPortfolio.com, we are part of the effort that is underway to drive major change in the investment industry.
Through the internet, we can share what what we know, and give average investors the chance to take control of their own money.
Online brokers have made it easy, and cheap, to manage your own money. And we give average investors sophisticated research in a very easy to understand format.
In fact, we make things very simple. Our customers pay us a quarterly subscription fee, and we give them open access to see our carefully designed portfolio of stocks that are owned by the world’s best billionaire investors and hedge funds – plus a lot more.
Our premium research service, The Billionaire’s Portfolio, is a hand picked portfolio of the 20 best ideas from the world’s best hedge funds and billionaire investors. We follow the world’s best investors. You follow us.
We will send you weekly emails with in depth analysis of these top ideas, along with very helpful perspectives on the global economy and broader markets. As a member to our Billionaire’s Portfolio, you will have full access to our website where you can track our full portfolio and read all of our past research notes.
If for any reason you find that the service doesn’t suit you, just email us within the first 30-days, and we will refund your money.
I encourage you to join now if you are interested.
We have two big central bank meetings this week–BOJ and the Fed. With that, as we head into the week, let’s look at a key chart.
This chart is from a St. Louis Fed blog post last year. The inflation data, however, is all up-to-date. The Fed says “the chart above shows eight series that receive a lot of attention in the context of policy.”
So according to this chart, last year, as the Fed was building into its first rate hike to move away from emergency level rates and policies, the inflation data was looking soft. The Fed was telegraphing, clearly, a September hike, though six of the eight inflation measures in the chart above were running south of their target of 2% in the middle of last year. The headline inflation number for September, their preferred date of a hike, was zero!
Of course, after markets went haywire following China’s currency devaluation in August of last year, the Fed balked and stood pat. When things calmed, in December, they made their move. And at the same meeting, they projected to hike FOUR times this year. So far it hasn’t happened. It’s been a one and done.
Moreover, as of March of this year, they took two of those projected hikes off the table, and guided lower on growth, lower on inflation and a lower rate trajectory into the future. I would argue removing two hikes from guidance was effectively easing.
But if we look at the chart above, where inflation stands now relative to the middle of last year, when they were all “bulled-up” on rates, the story doesn’t jive. By all of the inflation measures, the economy is clearly running hotter (a relative term). Five of the eight inflation measures are running ABOVE the Fed’s 2% target (the horizontal black line in the chart). Yet, aside from a few Fed hawks that have been out trying to build expectations for a rate move soon, on balance, the messaging from the Fed has been mixed at best, if not dovish.
The Bernanke-led Fed relied heavily on communication (i.e. massaging sentiment and perception) to orchestrate the recovery, but the Fed, under Yellen, has been a communications disaster.
Join us here to get all of our in-depth analysis on the bigger picture, and our carefully curated stock portfolio of the best stocks that are owned and influenced by the world’s best investors.
Since Friday of last week, there have been a lot of reports on the spike in the VIX. Today I want to talk about the VIX and the performance of major benchmark markets over the past week.
In a world where stability is king, central bankers have been very sensitive to swings in key financial markets, with the idea that confidence and the perception of stability can quickly become unhinged by market moves. When that happens, it becomes a big, viable threat to the global economic recovery and outlook. It can certainly send policy intentions off of the rails (as we’ve seen happen time and time again with the Fed).
Should they be worried?
With the above said, some might think the biggest threat to a Fed move in September (or December) isn’t economic data, but this chart.
Sources: Reuters, Forbes Billionaire’s Portfolio
First, what is the VIX? The VIX is an index that tracks the implied volatility of the S&P 500 index. What is implied volatility? It’s not actual volatility as might be measured by the dispersion of data from is mean.
Implied vol has more to do with the level of certainty that market makers have or don’t have about the future. When big money managers come calling for an option to hedge against potential downside in stocks, a market maker on the floor in Chicago at the CME prices the option with some objective inputs. And the variable input is implied volatility. When uncertainty is rising, the implied volatility value includes some premium over actual volatility. In short, if you’re a market maker and you think there is rising risk for a (as an example) a sharp decline in stocks, you will charge the buyer of that protection more, just as an insurance company would charge a client more for a homeowners policy in an area more included to see hurricanes.
So with that in mind, the implied vol market for the S&P 500 had been very subdued for the past 45 days or so, quickly falling back to complacency levels following the Brexit fears of late June. But since Friday, when market interest rates on government bonds spiked sharply (in the U.S., German, Japan), the VIX spiked from 12 to 20 (a more than 60% move).
That indicates a couple of things: 1) Stock investors were spooked by the move in rates and immediately looked for some downside protection, and 2) market makers aren’t quite as complacent as they appeared when the VIX was muddling along at low levels. They are quick to raise the insurance premium, highly spooked by the risk of a sharp decline in stocks.
But it looks like this recent spike might have more to do with market maker community that is psychologically damaged by the abrupt market moves of the past eight years. Gold is down since Friday – giving the opposite message of what the VIX is giving us about perceived uncertainty (people smell fear, they buy gold). And the S&P 500 has only lost 1.3% from its peak last Friday.
